Preliminary study of activity of the thioredoxin inhibitor pleurotin against Trichophyton mentagrophytes: A novel anti-dermatophyte possibility

Mycoses

Volumn 52, Issue 4, 2009, Pages 313-317

  Berdicevsky, Israela ^a   Kaufman, Gil ^a   Newman, David J ^b   Horwitz, Benjamin A ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antifungal activity; Candida spp; Dermatophytes; Trichophyton mentagrophytes

Indexed keywords

ANTIFUNGAL AGENT; NATURAL PRODUCT; PLEUROTIN; PROTEIN INHIBITOR; THIOREDOXIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DERMATOMYCOSIS; EXPERIMENTAL MODEL; FUNGAL COLONIZATION; FUNGUS GROWTH; HUMAN; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRICHOPHYTON MENTAGROPHYTES;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG EVALUATION, PRECLINICAL; FUNGAL PROTEINS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; MICROBIAL SENSITIVITY TESTS; SKIN; THIOREDOXINS; TINEA; TRICHOPHYTON;

ARTHRODERMA BENHAMIAE; ARTHRODERMATACEAE; CANDIDA; CANDIDA ALBICANS; TRICHOPHYTON;

EID: 67249143633     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01620.x     Document Type: Article

References (14)

1. Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995 8 : 240 59.
2. Hay RJ. How do dermatophytes survive in the epidermis? Curr Opin Infect Dis 2006 19 : 125 6.
3. Kaufman G, Berdicevsky I, Woodfolk JA, Horwitz BA. Markers for host-induced gene expression in Trichophyton dermatophytosis. Infect Immun 2005 73 : 6584 90.
4. Maranhao FC, Paiao FG, Martinez-Rossi NM. Isolation of transcripts over-expressed in human pathogen Trichophyton rubrum during growth in keratin. Microb Pathog 2007 43 : 166 72.
5. Missall TA, Lodge JK. Function of the thioredoxin proteins in Cryptococcus neoformans during stress or virulence and regulation by putative transcriptional modulators. Mol Microbiol 2005 57 : 847 58.
6. Thon M, Al-Abdallah Q, Hortschansky P, Brakhage AA. The thioredoxin system of the filamentous fungus Aspergillus nidulans: impact on development and oxidative stress response. J Biol Chem 2007 282 : 27259 69.
7. Oh JH, Chung AS, Steinbrenner H, Sies H, Brenneisen P. Thioredoxin secreted upon ultraviolet A irradiation modulates activities of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in human dermal fibroblasts. Arch Biochem Biophys 2004 423 : 218 26.
8. Welsh SJ, Williams RR, Birmingham A, Newman DJ, Kirkpatrick DL, Powis G. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1a and vascular endothelial growth factor formation. Mol Cancer Ther 2003 2 : 235 43.
9. Shipley SM, Barr AL, Graf SJ, Collins RP, McCloud TG, Newman DJ. Development of a process for the production of the anticancer lead compound pleurotin by fermentation of Hohenbuehelia atrocaerulea. J Ind Microbiol Biotechnol 2006 33 : 463 8.
10. Kaufman G, Horwitz BA, Duek L, Ullman Y, Berdicevsky I. Infection stages of the dermatophyte pathogen Trichophyton: microscopic characterization and proteolytic enzymes. Med Mycol 2007 45 : 149 55.
11. Onyewu C, Eads E, Schell WA et al. Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model. Antimicrob Agents Chemother 2007 51 : 3743 6.
12. Duek L, Kaufman G, Ulman Y, Berdicevsky I. The pathogenesis of dermatophyte infections in human skin sections. J Infect 2004 48 : 175 80.
13. Belozerov VE, Van Meir EG. Hypoxia inducible factor-1: a novel target for cancer therapy. Anticancer Drugs 2005 16 : 901 9.
14. Kunkel M, Kirkpatrick D, Johnson J, Powis G. Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs. Anticancer Drug Des 1997 12 : 659 70.